Astrazeneca said yesterday that crestor, its cholesterol-lowering drug, was unlikely to be approved in th ...
Astrazeneca said yesterday that crestor, its cholesterol-lowering drug, was unlikely to be approved in the united states until late next year because it must provide new data to the food and drug admi ...